GDC-0980 is an orally bioavailable inhibitor of phosphoinositide-3-kinase (PI3K) and mammalian target of rapamycin (mTOR), with potential antineoplastic activity.
Idelalisib;GS-1101;CAL-101
C26H28N8O4
Pharmaceutical , Specialty Chemicals , Research and Development
499.943